Glycogen storage disease type III other imaging findings
Glycogen storage disease type III Microchapters |
Differentiating Glycogen storage disease type III from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type III other imaging findings On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type III other imaging findings |
FDA on Glycogen storage disease type III other imaging findings |
CDC on Glycogen storage disease type III other imaging findings |
Glycogen storage disease type III other imaging findings in the news |
Blogs on Glycogen storage disease type III other imaging findings |
Risk calculators and risk factors for Glycogen storage disease type III other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Dual energy X-ray absorptiometry (DXA) may be helpful in the diagnosis of low bone mineral density (BMD) in patients with glycogen storage disease type 3.
Other Imaging Findings
Dual Energy X-ray Absorptiometry
- Glycogen storage disease type 3 associated with low bone mineral density (BMD) due to:[1]
- Abnormal muscle physiology
- Poor metabolic control
- Altered nutrition affecting micronutrient
- Dual energy X-ray absorptiometry is used to diagnose low bone mineral density (BMD).
References
- ↑ Mundy HR, Williams JE, Lee PJ, Fewtrell MS (2008). "Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit". J Inherit Metab Dis. 31 (3): 418–23. doi:10.1007/s10545-008-0830-0. PMID 18392743.